Home > Insider Trading > Filing (0001127602-24-010327)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1878313	Maia Biotechnology Inc.	MAIA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1913199	Stan Smith	444 West Lake Street, Suite 1700 Chicago IL 60606		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-03-14	170,940	$1.17	857,568	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants	Acquisiton	2024-03-14	170,940	$1.30	170,940	$1.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
170,940	2024-09-14	2029-09-14	No	4	P	Indirect

Footnotes

The common stock was purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024.
These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
The warrants were purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024. The options are exercisable beginning on the six month anniverary of the issuance date and expire 5-years after the initial exercise date.
These securities are beneficailly owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.